Literature DB >> 8950067

Effects of AWD 23-111, a new antiarrhythmic substance, on cardiac conduction and refractoriness.

U Stark1, G Stark, I Schwarzl, H Poppe, D Marx, M Decrinis, H A Tritthart.   

Abstract

In isolated spontaneously beating guinea pig hearts, the effects of AWD 23-111 (N-(dicyclohexylcarbamoylmethyl)-N-(3-diethylamino-propyl)-4-nit robenzamid -hydrochloride), a new synthetic class III antiarrhythmic agent with sodium antagonistic properties, were investigated on cardiac electrophysiological parameters, that is, conduction and refractoriness. Concentration-dependent prolongation of the atrioventricular, intraventricular, and His bundle conduction times and of sinus node cycle length were present. At 0.3 microM the repolarization period was prolonged significantly. No reverse use-dependent effect on the repolarization period was observed. During rapid pacing (pacing cycle length = 120 ms for the ventricle and 180 ms for the atrium) the rate-dependent intraventricular (QRS) or atrioventricular conduction time (AVCT) prolongation follows an exponential function of the beat number and is characterized by a drug-specific time constant. The time constant for the intraventricular conduction time prolongation in the presence of 0.1 microM AWD 23-111 was very long at 150 +/- 29 beats (mean +/- SEM; n = 6), indicating a slow binding kinetic to the sodium channel. At 0.1 microM AWD 23-111, a significant increase in the ventricular effective refractory period was reached when the interstimulus interval (S1-S1) was 120 ms and the number of conditioning stimuli (S1) was higher than the time constant. The time constant for the rate-dependent AVCT prolongation in the presence of 0.3 microM AWD 23-111 was 34 +/- 6 beats (n = 6). The effective refractory period of the atrioventricular conduction significantly increased with the number of conditioning stimuli (S1), until the number was comparable with the time constant. In conclusion, AWD 23-111 exerts a wide variety of actions on the cardiac conduction system. Its combined effects on the potassium and sodium channels seem to be responsible for the marked rate-dependent effect on ventricular refractoriness and for the lack of a reverse use-dependency on JT prolongation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8950067     DOI: 10.1007/bf00050993

Source DB:  PubMed          Journal:  Cardiovasc Drugs Ther        ISSN: 0920-3206            Impact factor:   3.727


  19 in total

1.  Assessment of the conduction of the cardiac impulse by a new epicardiac surface and stimulation technique (SST-ECG) in Langendorff perfused mammalian hearts.

Authors:  G Stark; U Stark; H A Tritthart
Journal:  J Pharmacol Methods       Date:  1989-05

2.  Atrioventricular nodal activation during periodic premature stimulation of the atrium.

Authors:  J Billette
Journal:  Am J Physiol       Date:  1987-01

Review 3.  Time- and voltage-dependent interactions of antiarrhythmic drugs with cardiac sodium channels.

Authors:  L M Hondeghem; B G Katzung
Journal:  Biochim Biophys Acta       Date:  1977-11-14

4.  Preliminary results of the Cardiac Arrest Study Hamburg (CASH). CASH Investigators.

Authors:  J Siebels; R Cappato; R Rüppel; M A Schneider; K H Kuck
Journal:  Am J Cardiol       Date:  1993-11-26       Impact factor: 2.778

5.  Class III antiarrhythmic agents have a lot of potential but a long way to go. Reduced effectiveness and dangers of reverse use dependence.

Authors:  L M Hondeghem; D J Snyders
Journal:  Circulation       Date:  1990-02       Impact factor: 29.690

6.  Comparison of the frequency-dependent effects on the atrioventricular node of verapamil, amiodarone, digoxin, and diltiazem in isolated guinea pig hearts.

Authors:  G Stark; C Schulze-Bauer; U Stark; K Kasper; M Decrinis; H A Tritthart
Journal:  J Cardiovasc Pharmacol       Date:  1995-02       Impact factor: 3.105

7.  Effects of flecainide and D-sotalol on myocardial conduction and refractoriness: relation to antiarrhythmic and proarrhythmic drug effects.

Authors:  G A Kidwell; M D Gonzalez
Journal:  J Cardiovasc Pharmacol       Date:  1993-04       Impact factor: 3.105

8.  How to measure AV nodal refractoriness in the presence of verapamil, amiodarone, digoxin, and diltiazem.

Authors:  G Stark; K Kasper; C Schulze-Bauer; U Stark; M Decrinis; H A Tritthart
Journal:  Pacing Clin Electrophysiol       Date:  1996-02       Impact factor: 1.976

9.  Reentrant arrhythmias in the subacute infarction period. The proarrhythmic effect of flecainide acetate on functional reentrant circuits.

Authors:  M Restivo; H Yin; E B Caref; A I Patel; G Ndrepepa; M J Avitable; M A Assadi; N Isber; N el-Sherif
Journal:  Circulation       Date:  1995-02-15       Impact factor: 29.690

10.  Electrophysiologic effects of detajmium on isolated dog cardiac ventricular and Purkinje fibers.

Authors:  O Hála; M Németh; A Varró; J G Papp
Journal:  J Cardiovasc Pharmacol       Date:  1994-10       Impact factor: 3.105

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.